Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 3, 2010, Pages 799-803

  Wilder, Richard B ^a   Curcio, Lisa D ^a   Khanijou, Rajesh K ^a   Eisner, Martin E ^a   Kakkis, Jane L ^a   Chittenden, Lucy ^a   Agustin, Jeffrey ^a   Lizarde, Jessica ^a   Mesa, Albert V ^a   MacEdo, Jorge C ^a   Ravera, John ^a   Tokita, Kenneth M ^a  

^a Cancer Center of Irvine   (United States)

Author keywords

Breast; Irradiation; Negative; Partial; Triple

Indexed keywords

PEPTIDES; TUMORS;

ACCELERATED PARTIAL BREAST IRRADIATION; BRACHYTHERAPY; BREAST; BREAST CANCER; BREAST CARCINOMAS; BREAST TUMOR; ESTROGEN RECEPTOR; GROWTH FACTOR; HUMAN EPIDERMAL GROWTH FACTOR; MAMMOSITE; NEGATIVE; OVERALL SURVIVAL; OVERALL SURVIVAL RATES; PARTIAL; PROGESTERONE RECEPTOR; RELAPSE-FREE SURVIVAL RATES; RICHARDSON; TRIPLE; TRIPLE NEGATIVE;

IRRADIATION;

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR PROTEIN;

ACCELERATED PARTIAL BREAST IRRADIATION; ADOLESCENT; ADULT; AGED; ARTICLE; BRACHYTHERAPY; BREAST CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CATHETER; CHILD; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; BREAST NEOPLASMS; CHEMISTRY; CHI SQUARE DISTRIBUTION; ETHNOLOGY; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; NONPARAMETRIC TEST; PATHOLOGY; RADIATION DOSE FRACTIONATION; REGRESSION ANALYSIS; SEGMENTAL MASTECTOMY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; DOSE FRACTIONATION; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 77957191754     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.08.081     Document Type: Article

References (40)

1. R.M. Clark, T. Whelan, and M. Levine Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update. Ontario Clinical Oncology Group J Natl Cancer Inst 88 1996 1659 1664
2. B. Fisher, S. Anderson, and J. Bryant Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 2002 1233 1241
3. K. Holli, R. Saaristo, and J. Isola Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: Results of a randomized study Br J Cancer 84 2001 164 169
4. G. Liljegren, L. Holmberg, and J. Bergh 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial J Clin Oncol 17 1999 2326 2333
5. U. Veronesi, E. Marubini, and L. Mariani Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial Ann Oncol 12 2001 997 1003
6. C. Polgar, J. Fodor, and T. Major Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma: 5-year results of a randomized trial Int J Radiat Oncol Biol Phys 69 2007 694 702
7. B.D. Smith, D.W. Arthur, and T.A. Buchholz Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO) Int J Radiat Oncol Biol Phys 74 2009 987 1001
8. S. Bensaleh, E. Bezak, and M. Borg Review of MammoSite brachytherapy: Advantages, disadvantages and clinical outcomes Acta Oncol 2008 1 8
9. R. Garza, K. Albuquerque, and A. Sethi Lung and cardiac tissue doses in left breast cancer patients treated with single-source breast brachytherapy compared to external beam tangent fields Brachytherapy 5 2006 235 238
10. A.J. Stewart, D.A. O'Farrell, and R.A. Cormack Dose volume histogram analysis of normal structures associated with accelerated intracavitary partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields Radiat Oncol 3 2008 39
11. M. Brown, A. Tsodikov, and K.R. Bauer The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999-2004 Cancer 112 2008 737 747
12. S. Cleator, W. Heller, and R.C. Coombes Triple-negative breast cancer: Therapeutic options Lancet Oncol 8 2007 235 244
13. G.M. Freedman, P.R. Anderson, and T. Li Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation Cancer 115 2009 946 951
14. R. Nishimura, and N. Arima Is triple negative a prognostic factor in breast cancer? Breast Cancer 15 2008 303 308
15. R. Dent, M. Trudeau, and K.I. Pritchard Triple-negative breast cancer: Clinical features and patterns of recurrence Clin Cancer Res 13 2007 4429 4434
16. B.G. Haffty, Q. Yang, and M. Reiss Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 24 2006 5652 5657
17. S.S. Zaky, M. Lund, and K.A. May Triple negative breast cancer confers higher recurrence rates after breast conserving therapy Int J Radiat Oncol Biol Phys 72 2008 S153 S154
18. J. Rhee, S.W. Han, and D.Y. Oh The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer BMC Cancer 8 2008 307
19. K.R. Bauer, M. Brown, and R.D. Cress Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California cancer Registry Cancer 109 2007 1721 1728
20. L. Dogan, C. Atalay, and K.B. Yilmaz Prognosis in hormon receptor negative breast cancer patients according to ERBB2 status Neoplasma 55 2008 544 548
21. L.J. Solin, W.T. Hwang, and N. Vapiwala Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma Clin Breast Cancer 9 2009 96 100
22. N. Mohideen, S.S. Nigh, and P.A. Lobo Are patients with triple negative breast cancer appropriately treated with accelerated partial breast irradiation (APBI)? Int J Radiat Oncol Biol Phys 72 2008 S198
23. J.M. Harvey, G.M. Clark, and C.K. Osborne Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer J Clin Oncol 17 1999 1474 1481
24. R.B. Wilder, L.D. Curcio, and R.K. Khanijou A Contura catheter offers dosimetric advantages over a MammoSite catheter that increase the applicability of accelerated partial breast irradiation Brachytherapy 8 2009 373 378
25. J.B. Strauss, and A. Dickler Accelerated partial breast irradiation utilizing balloon brachytherapy techniques Radiother Oncol 91 2009 157 165
26. J.B. Wojcicka, D.E. Lasher, and R. Malcom Clinical and dosimetric experience with MammoSite-based brachytherapy under the RTOG 0413 protocol J Appl Clin Med Phys 8 2007 2654
27. O.J. Ott, G. Hildebrandt, and R. Potter Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial Radiother Oncol 82 2007 281 286
28. A. Recht, B. Silver, and S. Schnitt Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage Int J Radiat Oncol Biol Phys 11 1985 1271 1276 (Pubitemid 15067909)
29. L.D. Cassidy Basic concepts of statistical analysis for surgical research J Surg Res 128 2005 199 206
30. Y. Chan, and R.P. Walmsley Learning and understanding the Kruskal-Wallis one-way analysis-of-variance-by-ranks test for differences among three or more independent groups Phys Ther 77 1997 1755 1762
31. K.J. Jager, P.C. van Dijk, and C. Zoccali The analysis of survival data: The Kaplan-Meier method Kidney Int 74 2008 560 565
32. D. Zhang, and H. Quan Power and sample size calculation for log-rank test with a time lag in treatment effect Stat Med 28 2009 864 879
33. P.C. van Dijk, K.J. Jager, and A.H. Zwinderman The analysis of survival data in nephrology: Basic concepts and methods of Cox regression Kidney Int 74 2008 705 709
34. M.A. Rose, I. Olivotto, and B. Cady Conservative surgery and radiation therapy for early breast cancer: Long-term cosmetic results Arch Surg 124 1989 153 157
35. C. Liedtke, C. Mazouni, and K.R. Hess Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer J Clin Oncol 26 2008 1275 1281
36. A.R. Tan, and S.M. Swain Therapeutic strategies for triple-negative breast cancer Cancer J 14 2008 343 351
37. R.R. Patel, M.E. Christensen, and C.W. Hodge Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: Five-year results Int J Radiat Oncol Biol Phys 70 2008 970 973
38. J.S. Jeruss, F.A. Vicini, and P.D. Beitsch Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast Ann Surg Oncol 13 2006 967 976
39. L.W. Cuttino, M. Keisch, and J.M. Jenrette Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results Int J Radiat Oncol Biol Phys 71 2008 107 114
40. F. Vicini, P.D. Beitsch, and C.A. Quiet Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI) Cancer 112 2008 758 766